Skip to main content

What If I Do Not Get Myself Treated for Crohn’s Disease? Natural History of Crohn’s Disease

  • Chapter
Inflammatory Bowel Disease
  • 1368 Accesses

Abstract

Crohn’s disease is a chronic inflammatory disease of your intestinal tract. The majority of patients with Crohn’s disease are diagnosed in the second or third decade of life. The process of inflammation in Crohn’s disease can involve any part of the intestinal tract, from the mouth to anus. Your intestinal tract is made of different layers just like layers of onion. Unlike ulcerative colitis, which involves only the inner most layer also known as mucosa, Crohn’s disease can affect all the different layers of your intestine. To date, we don’t have a cure for this inflammation, and the goal of our therapy is to suppress and keep the inflammation down and prevent the complications of the disease. If left untreated, most patients will have intermittent periods of worsening of disease called flares followed by period of feeling better called remission. Some patients can go in remission for a long time after their first flare. It is hard to determine which patients will follow that pattern. However, without treatment most patients will have repeated attacks of mild to severe symptoms with ongoing damage to the lining of the GI tract. This ongoing process of inflammation can lead to scar formation that may cause abnormal narrowing of the intestine called a stricture or abnormal communications between different parts of intestinal tract called fistulas. Fistulas may also form between the intestinal tract and other organs as the vagina and urinary bladder or to the skin. All of these lead to an increased need of surgery with recurrence afterwards. Long-term difficulty to absorb nutrition in untreated CD can also lead to severe malnutrition, anemia, dehydration, weight loss, and lack of immunity to fight infections. All these complications can be debilitating and even life threatening if not recognized and treated in timely fashion. The risk of complicated disease increases if you are diagnosed at an early age or smoke cigarettes. Different types of immunosuppressive medications are prescribed not only to bring inflammation down but also keep it suppressed with the goal to keep the symptoms away; prevent flares, hospitalization, and surgical and nutritional complications; and improve the quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Farmer RG, Hawk WA, Turnbull RB. Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology. 1975;68(4):627–35.

    CAS  PubMed  Google Scholar 

  2. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49(6):777–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn’s disease patients. Scand J Gastroenterol. 1995;30(7):699–706.

    Article  CAS  PubMed  Google Scholar 

  4. Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn’s disease: Markov model analysis of a population-based cohort. Gastroenterology. 1999;117(1):49–57.

    Article  CAS  PubMed  Google Scholar 

  5. Levy C, Tremaine WJ. Management of internal fistulas in Crohn’s disease. Inflamm Bowel Dis. 2002;8(2):106–11.

    Article  PubMed  Google Scholar 

  6. Langholz E. Current trends in inflammatory bowel disease: the natural history. Ther Adv Gastroenterol. 2010;3(2):77–86.

    Article  Google Scholar 

  7. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 1988;29(5):588–92.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Feagan BG, Panaccione R, Sandborn WJ, D’Haens GR, Schreiber S, Rutgeerts PJ, Loftus EV, Lomax KG, Yu AP, Wu EQ, Chao J, Mulani P. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn’s disease: results from the CHARM study. Gastroenterology. 2008;135:1493–9.

    Article  CAS  PubMed  Google Scholar 

  9. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D’Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;362:1383–95.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tauseef Ali M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ali, T. (2015). What If I Do Not Get Myself Treated for Crohn’s Disease? Natural History of Crohn’s Disease. In: Stein, D., Shaker, R. (eds) Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-14072-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14072-8_6

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14071-1

  • Online ISBN: 978-3-319-14072-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics